11
Participants
Start Date
April 30, 2009
Primary Completion Date
August 31, 2009
Study Completion Date
AZD1446
Solution, oral, single dose
2-[18F]-F-A85380
iv, single dose
Research Site, Stockholm
Lead Sponsor
AstraZeneca
INDUSTRY